
feb pm et
summari compani spun bristol-my squibb august manufactur orthoped
reconstruct implant fractur manag product dental implant
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
stock trade
look sale rise
partli off-set price pressur
market on-going suppli chain constraint
first encount first half
continu throughout first three
quarter expect suppli
constraint continu
report five product categori knee
hip spine dental surgic sport
medicin foot ankl extrem
trauma account sale
see spine grow
mid-singl digit next two year
segment grow
low-singl digit see knee hip
account sale rebound
daniel florin serv interim ceo
ldr hold provid surgic
technolog spine disord
june zimmer acquir biomet inc
second-largest firm
musculoskelet market
market share see
synergi year-end cumul
synergi
see ep
think share trade
forward ep estim
peer near fair valu think
remain constrain suppli chain
constraint disrupt warsaw
facil think issu larg price
share forese issu
resolv mid think biomet
acquisit make strateg sens two
compani broad portfolio
complementari also enabl
expand faster grow sport
extrem trauma market also
long-term global demand driver
popul rise obes level also
view ldr deal posit strengthen
spine portfolio current
small market share activist
investor jana partner announc juli
stake
risk recommend target price
includ lower medicar reimburs
reimburs cut key oversea market
integr challeng
target price
peer forward ep
estim account suppli chain
risk assess reflect zimmer oper
highli competit industri character rel
short product life cycl requir signific number
new product maintain market share mani custom
reimburs medicar restrict
budgetari environ could result price pressur
howev believ market leadership posit
divers product offer allevi inher
fiscal year end dec ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview zimmer biomet form june merger zimmer
hold biomet primarili design develop manufactur market orthoped
reconstruct implant fractur manag product former divis bristol-my squibb
spun sharehold august
zimmer reconstruct implant use restor function lost due diseas trauma joint
knee hip shoulder elbow compani offer wide rang product special knee
total knee m/g unicompartment knee prolong highli crosslink polyethylen
articular surfac materi hip replac product includ versi hip system zmr hip system
trilog acetabular system line specialti hip product compani also continu develop
portfolio minim invas hip replac procedur sell coonrad/morrey product line
elbow replac implant product along line restor dental product
spine trauma area compani sell devic use reattach stabil damag bone
tissu support bodi natur heal process common stabil bone fractur
concern intern fixat bone fragment involv use assort plate
screw rod wire pin offer line product design use fractur fixat octob
compani acquir spinal busi abbott lab million cash
make market orthoped surgic product use surgeon orthoped well
non-orthoped procedur product includ tourniquet blood manag system wound
de-bridg product power surgic instrument pain manag devic orthoped soft
good provid support and/or heat retent compress trauma knee ankl back
upper extrem includ shoulder elbow neck wrist
competit landscap zimmer oper competit global market success often due
technolog innov product qualiti brand reput custom relationship servic
factor heighten barrier entri competit high among exist particip
well capit larg experienc sale forc within global market orthoped devic
zimmer compet johnson johnson stryker smith nephew
spinal implant categori compani compet princip
impact major develop june zimmer acquir biomet transact valu
billion connect transact zimmer chang name zimmer biomet ticker
symbol new york stock exchang chang zmh combin compani leader
musculoskelet market juli zimmer acquir ldr hold billion ldr medic
devic compani focus proprietari surgic technolog treatment patient suffer
senior vice presid
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli overvalu
bullish sinc decemb technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
equip sub-industri next month
neutral continu view mani product
categori histor recession-resist
expect continu grow albeit
slowli growth procedur rate
slow area normal view
non-elect cardiac rhythm
manag intervent cardiolog
orthoped recent howev equip
maker think certain procedur rate may
stabil start recov
medic devic tax requir
healthcar reform law went effect
januari temporarili
suspend
elect donald trump republican
retain control congress believ
gop abil substanti alter
afford act includ potenti
elimin variou health care sector fee
tax although gop replac
remain uncertain believ
potenti fewer insur patient
neg impact equip sub-industri
fewer insur patient would like lead
fewer procedur anticip
hospit largest buyer
medic equip would also advers
impact could pressur
expect revenu rise constant
currenc mid- upper-singl digit pace
aid new product expans emerg
market case acquisit
still expect extend replac cycl
 hospit area price
demand certain product categori
unfavor foreign exchang continu
hospit becom cautiou regard
base index
five-year market price perform feb
capit budget amid shift
procedur inpati outpati
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
sub-index increas vs rise
 composit index follow
rise health equip
index vs declin
composit index year date
juli health
equip index rose vs rise
 composit index
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
analyst research note compani news
inc announc bryan hanson appoint
presid chief execut offic member board director
effect dec daniel florin serv interim ceo sinc
juli continu role senior vice presid chief
financi offic mr hanson join zimmer biomet year
experi medic devic industri recent serv member
execut committe execut vice presid
presid minim invas therapi group
march paul bisaro member board director zimmer
biomet hold inc notifi chairman board stand
reelect compani annual meet stockhold mr bisaro
continu serv director member compens
manag develop committe corpor govern committe
board current term expir annual meet board intend
reduc size eleven member effect upon expir mr bisaro term
director
hold inc lower target price
below-p forward ep estim see
continu suppli chain challeng advers impact sale market share
think capac issu warsaw plant continu
could put share risk ep vs
estim lower ep estim
sale fell knee product hip
 sale rose knee sale hurt lower price
biomet hold keep target
peer revis ep estim
account price pressur on-going improv suppli
chain constraint expect suppli chain issu resolv
set ep estim ep vs
ahead estim sale rose improv knee hip
busi sale continu strength unit guid
sale growth includ advers fx ep
buy keep target price below-p
forward ep estim ep vs
estim lower ep estim
cfo daniel florin serv interim ceo
follow resign david dvorak earlier month sale rose
aid inclus ldr hold knee hip sale
 sale rose believ remain constrain
suppli chain issu disrupt warsaw facil /jeffrey loo
et capit iq keep buy opinion share zimmer
biomet hold inc lower target
peer next ep estim
suppli chain constraint see correct earli also
encourag product portfolio strategi includ rosa robot
technolog focus brain spine applic ep vs
estim lower ep estim sale
rose solid demand unit asia overal
forecast weaker-than-expect sale larg joint dental
juli inc announc adam johnson
group presid spine dental craniomaxillofaci thorac
busi unit resign effect septemb mr johnson inform
compani integr ldr substanti complet new
leader place zimmer biomet spine dental busi unit chri
jefferi vice presid financ spine dental craniomaxillofaci
thorac serv interim group presid perman successor
name mr jefferi report directli daniel florin interim
chief execut offic senior vice presid chief offic
inc announc david dvorak step
presid chief execut offic member board
director effect juli assist transit mr dvorak
serv advisori capac compani period time
board appoint daniel florin senior vice presid chief
financi offic serv addit role interim ceo member
board director perman successor name
florin appoint senior vice presid chief offic
zimmer biomet june year execut experi
medic devic industri previous serv senior vice presid
chief offic biomet june june
hold inc keep target
peer ep estim ep
vs estim lower ep
sale rose knee sale hip
continu advers impact suppli constraint product remain
interrupt warsaw facil think on-track restor
adequ suppli acceler growth updat sale
guidanc growth ep
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
